Convincing improvement in OA In a 2024 paper published in T he New England Journal of Medicine, Bliddal and colleagues enrolled 407 patients with knee OA and obesity in a double-blind, randomized, placebo-controlled trial, called STEP-9, at 61 sites across 11 countries
Patients with cirrhosis require ongoing surveillance for hepatocellular carcinoma with ultrasound (with or without alpha-fetoprotein) every six months, regardless of weight loss treatment
Based on the most recent data available for this final rule with comment period, the target PCR now equals the PCR of non-cancer ( hospitals
CJC-1295 DAC has an extended half-life of 6-8 days due to albumin binding, providing sustained GH elevation
Compounded glucagon-like peptide-1 receptor agonists (GLP-1RA) products are not identical to the TGA-approved products Ozempic (semaglutide) or Mounjaro (tirazapetide)